Cite
HARVARD Citation
Rocca, C. et al. (2019). Physiological levels of chromogranin A prevent doxorubicin‐induced cardiotoxicity without impairing its anticancer activity. FASEB journal. 33 (6), pp. 7734-7747. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rocca, C. et al. (2019). Physiological levels of chromogranin A prevent doxorubicin‐induced cardiotoxicity without impairing its anticancer activity. FASEB journal. 33 (6), pp. 7734-7747. [Online].